268 filings
Page 3 of 14
8-K
NNMX
NANOMIX Corp
2 Mar 22
Nanomix Completes 1-for-173 Reverse Stock Split
5:27pm
8-K
NNMX
NANOMIX Corp
1 Mar 22
Entry into a Material Definitive Agreement
8:58am
SC 13G
NNMX
NANOMIX Corp
7 Feb 22
NANOMIX / Hudson Bay Capital Management ownership change
3:44pm
8-K
NNMX
NANOMIX Corp
17 Nov 21
Other Events
12:00am
10-Q
2021 Q3
NNMX
NANOMIX Corp
Quarterly report
15 Nov 21
4:42pm
8-K
NNMX
NANOMIX Corp
5 Nov 21
Regulation FD Disclosure
5:06pm
8-K/A
NNMX
NANOMIX Corp
5 Nov 21
Other Events
4:47pm
UPLOAD
NNMX
NANOMIX Corp
21 Oct 21
Letter from SEC
12:00am
DEF 14C
NNMX
NANOMIX Corp
20 Oct 21
Information statement
3:43pm
S-1
NNMX
NANOMIX Corp
IPO registration
15 Oct 21
5:08pm
10-Q
2021 Q2
NNMX
NANOMIX Corp
Quarterly report
4 Oct 21
9:59pm
8-K
NNMX
NANOMIX Corp
10 Sep 21
Amendments to Articles of Incorporation or Bylaws
2:05pm
PRE 14C
NNMX
NANOMIX Corp
9 Sep 21
Preliminary information
4:37pm
8-K/A
NNMX
NANOMIX Corp
27 Aug 21
Management’s Discussion and Analysis of Financial Condition and Results of Operations
12:00am
NT 10-Q
NNMX
NANOMIX Corp
16 Aug 21
Notice of late quarterly filing
4:30pm
SC 14F1
NNMX
NANOMIX Corp
23 Jul 21
Statement regarding change in majority of directors
5:00pm
D
NNMX
NANOMIX Corp
9 Jul 21
$8.43M in debt / options, sold $8.43M, 5 investors
3:05pm
3
NNMX
NANOMIX Corp
29 Jun 21
Boston Therapeutics / DAVID LUDVIGSON ownership change
8:46pm
8-K
NNMX
NANOMIX Corp
29 Jun 21
Boston Therapeutics Announces $8.4 Million Convertible Placement
9:06am
10-Q
2021 Q1
NNMX
NANOMIX Corp
Quarterly report
14 Jun 21
3:19pm